(Q46733366)

English

Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

0 references

multiple myeloma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Pieter Sonneveld

1

object named as

Pieter Sonneveld

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

Robert Z Orlowski

9

object named as

Robert Z Orlowski

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

0 references

6

object named as

Tadeusz Robak

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

author name string

Roman Hajek

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

Arnon Nagler

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

Andrew Spencer

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

Joan Bladé

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

Sen H Zhuang

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

Jean-Luc Harousseau

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

DOXIL-MMY-3001 Study Investigators

10

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

language of work or name

0 references

publication date

1 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

112

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

1529-1537

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

New approaches to treatment for multiple myeloma: durable remission and quality of life as primary goals

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23326

7 January 2021

based on heuristic

inferred from DOI database lookup

Review of 1027 patients with newly diagnosed multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23326

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide as initial therapy for early-stage myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23326

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23326

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiac safety of liposomal anthracyclines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23326

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed-refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23326

7 January 2021

based on heuristic

inferred from DOI database lookup

Lenalidomide: patient management strategies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23326

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23326

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide therapy for myelodysplastic syndromes: current status and future perspectives.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23326

7 January 2021

based on heuristic

inferred from DOI database lookup

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23326

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23326

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23326

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18300257

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46733366&oldid=2129008491"